Sawai Group Holdings Co., Ltd. (TYO:4887)
Japan · Delayed Price · Currency is JPY 1,921.00
-8.00 (-0.41%)
Aug 22, 2025, 3:30 PM JST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
Cardiovascular Drugs | 42.57B | Log In | Log In | Log In | Log In | Upgrade |
Cardiovascular Drugs Growth | 1.02% | Log In | Log In | Log In | Log In | Upgrade |
Central Nervous System Drugs | 25.71B | Log In | Log In | Log In | Log In | Upgrade |
Central Nervous System Drugs Growth | 4.64% | Log In | Log In | Log In | Log In | Upgrade |
Other Metabolic Drugs | 20.56B | Log In | Log In | Log In | Log In | Upgrade |
Other Metabolic Drugs Growth | 13.32% | Log In | Log In | Log In | Log In | Upgrade |
Digestive Medicine | 20.40B | Log In | Log In | Log In | Log In | Upgrade |
Digestive Medicine Growth | 6.88% | Log In | Log In | Log In | Log In | Upgrade |
Blood and Body Fluid Drugs | 17.82B | Log In | Log In | Log In | Log In | Upgrade |
Blood and Body Fluid Drugs Growth | 11.32% | Log In | Log In | Log In | Log In | Upgrade |
Antibiotics | 10.67B | Log In | Log In | Log In | Log In | Upgrade |
Antibiotics Growth | 15.09% | Log In | Log In | Log In | Log In | Upgrade |
Allergy Medications | 8.90B | Log In | Log In | Log In | Log In | Upgrade |
Allergy Medications Growth | 28.01% | Log In | Log In | Log In | Log In | Upgrade |
Vitamin Supplements | 7.12B | Log In | Log In | Log In | Log In | Upgrade |
Vitamin Supplements Growth | -3.37% | Log In | Log In | Log In | Log In | Upgrade |
Chemotherapeutic Agents | 7.02B | Log In | Log In | Log In | Log In | Upgrade |
Other | 28.26B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 3.76% | Log In | Log In | Log In | Log In | Upgrade |
Oncology Drugs | - | Log In | Log In | Log In | Log In | Upgrade |
Genitourinary and Anal Drugs | - | Log In | Log In | Log In | Log In | Upgrade |
Genitourinary and Anal Drugs Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
Japan | 189.02B | Log In | Log In | Log In | Log In | Upgrade |
Japan Growth | 6.88% | Log In | Log In | Log In | Log In | Upgrade |
United States | - | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | - | Log In | Log In | Log In | Log In | Upgrade |